USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/7306
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSpinu, C.
dc.contributor.authorBirca, L.
dc.contributor.authorSpinu, I.
dc.contributor.authorCornilov, S.
dc.contributor.authorPantea, V.
dc.date.accessioned2020-01-20T10:48:15Z
dc.date.available2020-01-20T10:48:15Z
dc.date.issued2014
dc.identifier.citationSPINU, C., BIRCA, L., SPINU, I., CORNILOV, S., PANTEA, V. Eficienţa preparatului autohton pacovirina în tratamentul mononucleozei infecţioase la copii. In: Curierul Medical. 2014, nr. 1(57), pp. 77-81. ISSN 1875-0666.en_US
dc.identifier.issn1857-0666
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/7306
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2016/09/Cm-1-57-1.pdf
dc.descriptionNational Center of Public Health, the Republic of Moldova, Municipal Infectious Diseases Hospital for Children, Chisinau, Toma Ciorba Hospital of Infectious Diseases, Chisinau, the Republic of Moldovaen_US
dc.description.abstractBackground: In the article are presented the clinical results of the treatment of children with infectious mononucleosis where the basic therapy has been combined with the administration of the local drug pacovirin which has antiviral, immunomodulatory, interferonogenic and antioxidant activity. Material and methods: Pacovirin has been administered for one month by 50 mg capsules 2 times a day per os. The object of study has been presented by 175 patients (84 patients in the experimental group and 91 ones in the comparison group) and the records of the patients surveillance (form 003/e), containing the clinical diagnosis of infectious mononucleosis with Epstein-Barr virus and hepatitis syndrome. The duration of the treatment has been one month, the doses being age-appropriate and applied 2 times a day. Results: The administration of pacovirin as a medicinal remedy in addition to the traditional treatment, in accordance with the method proposed by us, has led to the more intensive normalization of clinical and laboratory indices, decrease of the pathological process and the rapid recovery of the patients, as well as the more intensive normalization of biochemical indices and significant reduction of the duration of the main clinical signs in the experimental group compared with the control group. Conclusions: The drug pacovirin has a positive effect on the main clinical signs of general toxic syndrome and digestive disorders, which have disappeared in a significant number of patients after the treatment. In most patients in the experimental group a decrease in the size of liver and spleen has been observed through palpatory evaluation by the end of the treatment course with pacovirin. In the the experimental group a positive dynamics of paraclinical indices (Alt, AST and γGTP) has been evident.en_US
dc.language.isoroen_US
dc.publisherThe Scientific Medical Association of the Republic of Moldovaen_US
dc.relation.ispartofCurierul Medical
dc.subjectinfectious mononucleosisen_US
dc.subjectchildrenen_US
dc.subjecttreatmenten_US
dc.titleEficienţa preparatului autohton Pacovirina în tratamentul mononucleozei infecţioase la copii
dc.title.alternativeEfficiency of the national drug Pacovirin in the treatment of infectious mononucleosis in children
dc.typeArticle
Appears in Collections:Curierul Medical, 2014, Vol. 57, Nr. 1

Files in This Item:
File Description SizeFormat 
Efficiency_of_the_national_drug_pacovirin_in_the_treatment.pdf1.25 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback